Vaxart Inc (STU:NB11) Stock News, Headlines & Updates
Vaxart Inc Stock News from GuruFocus
- 1
- 2
Jul 08, 2025
Vaxart Announces Trading on OTCQX Best Market
Marketwired • 7:00am
Jun 13, 2025
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
GlobeNewswire • 5:00pm
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders | VXRT Stock News
GuruFocus News • 4:15pm
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
Marketwired • 4:00pm
Jun 11, 2025
Vaxart (VXRT) Shares Soar After Promising Norovirus Vaccine Trial Results
GuruFocus News • 9:58am
Vaxart Jumps 38% After Positive Norovirus Trial
Moz Farooque • 9:26am
Vaxart (VXRT) Unveils Promising Phase 1 Results for New Norovirus Vaccine | VXRT Stock News
GuruFocus News • 7:15am
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
Marketwired • 7:00am
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology | VXRT Stock News
GuruFocus News • 6:46am
Jun 10, 2025
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial | VXRT Stock News
GuruFocus News • 4:00pm
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
Marketwired • 4:00pm
Jun 02, 2025
Vaxart Announces Adjournment of Annual Meeting of Stockholders
Marketwired • 4:00pm
Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News
GuruFocus News • 3:45pm
May 29, 2025
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
Marketwired • 4:00pm
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 | VXRT Stock News
GuruFocus News • 3:20pm
Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders
Marketwired • 8:00am
Vaxart (VXRT) Releases Video Update Urging Support for Reverse Stock Split | VXRT Stock News
GuruFocus News • 7:48am
Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders | VXRT Stock News
GuruFocus News • 7:17am
May 28, 2025
Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Meeting | VXRT Stock News
GuruFocus News • 7:46am
Vaxart Answers Additional Frequently Asked Questions from Retail Investors
Marketwired • 7:00am
May 27, 2025
Vaxart (VXRT) Advances in Phase 2b Trial with Oral COVID-19 Vaccine | VXRT Stock News
GuruFocus News • 7:32am
Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
Marketwired • 7:00am
May 21, 2025
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire • 5:00pm
Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News
GuruFocus News • 4:00pm
Vaxart Announces Adjournment of Annual Meeting of Stockholders
Marketwired • 4:00pm
May 20, 2025
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • 5:00pm
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 5:00pm
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VXRT Stock News
GuruFocus News • 4:17pm
May 16, 2025
Vaxart (VXRT) Eyes Reverse Stock Split to Secure Nasdaq Listing | VXRT Stock News
GuruFocus News • 7:33am
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting | VXRT Stock News
GuruFocus News • 7:30am
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
Marketwired • 7:00am
May 15, 2025
Vaxart (VXRT) Secures BARDA Approval for Next Phase of COVID-19 Vaccine Trial | VXRT Stock News
GuruFocus News • 7:46am
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
Marketwired • 7:00am
May 14, 2025
Vaxart (VXRT) Rises After Positive Trial Results for Norovirus Vaccine
GuruFocus News • 5:01pm
Vaxart (VXRT) Unveils Promising Results from Phase 2b Norovirus Vaccine Study | VXRT Stock News
GuruFocus News • 4:16pm
Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine
Marketwired • 4:00pm
Vaxart Inc (VXRT) Q1 2025 Earnings Call Highlights: Strategic Progress Amidst Challenges
GuruFocus News • 1:14am
Q1 2025 Vaxart Inc Earnings Call Transcript
GuruFocus News • 11:08pm
Vaxart (VXRT) Advances COVID-19 and Norovirus Vaccine Trials
GuruFocus News • 7:56pm
May 13, 2025
Vaxart Appoints Jeroen Grasman as Chief Financial Officer
Marketwired • 4:00pm
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news